Comments
Ranbaxy Laboratories said on Tuesday that its consolidated net profit after tax (PAT) surged over five fold to Rs 1496.8 crore for the year ended December 31, 2010.
In a filing to the BSE the company said that it had posted a profit after tax of Rs 296.5 crore in the previous fiscal.
The company’s total income rose to Rs 9380.95 crore for the year ended December 31, 2010, compared to Rs 7986.57 crore in the last year.
The company’s board, at its meeting held today, has recommended a dividend of Rs 2 per equity share for the year.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.